Harmony Biosciences Holdings, Inc.
HRMY
$38.05
$0.882.37%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.70% | -7.91% | 7.34% | 297.66% | -69.76% |
| Total Depreciation and Amortization | -0.02% | 0.00% | 0.00% | -1.39% | -1.18% |
| Total Amortization of Deferred Charges | -1.81% | -1.78% | -3.43% | -0.57% | -2.22% |
| Total Other Non-Cash Items | 144.28% | 97.27% | -36.99% | -83.31% | 475.58% |
| Change in Net Operating Assets | 152.20% | -263.52% | 35.13% | 180.64% | 28.60% |
| Cash from Operations | 133.40% | -55.02% | 7.18% | 65.43% | 36.85% |
| Capital Expenditure | 96.88% | 75.05% | -17,000.00% | 99.53% | -12,540.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -886.55% | 137.31% | -992.25% | 103.54% | -242.26% |
| Cash from Investing | -929.34% | 132.86% | -1,064.70% | 101.36% | -786.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -55.44% | 45.38% | 25.71% | 349.39% | 393.97% |
| Repurchase of Common Stock | 21.02% | 41.29% | -- | 100.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -663.07% | 87.16% | -133.28% | 65.90% | 5.17% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 58.49% | -45.15% | -6.33% | 546.74% | -173.57% |